34 related articles for article (PubMed ID: 11506480)
1. Sarcomatoid renal pelvis carcinoma: Experience of treatment at a single-institution.
Liu T; Yao Y; Geng C; Guan F; Zhang G
Eur J Surg Oncol; 2024 Jun; 50(6):108251. PubMed ID: 38492258
[TBL] [Abstract][Full Text] [Related]
2. The Pathology and Molecular Genetics of Sarcomatoid Renal Cell Carcinoma: A Mini-Review.
Wei S; Al-Saleem T
J Kidney Cancer VHL; 2017; 4(2):19-23. PubMed ID: 28725540
[TBL] [Abstract][Full Text] [Related]
3. RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.
Pal SK; He M; Tong T; Wu H; Liu X; Lau C; Wang JH; Warden C; Wu X; Signoretti S; Choueiri TK; Karam JA; Jones JO
Mol Cancer Res; 2015 Jan; 13(1):130-7. PubMed ID: 25183163
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.
Shuch B; Bratslavsky G; Linehan WM; Srinivasan R
Oncologist; 2012; 17(1):46-54. PubMed ID: 22234634
[TBL] [Abstract][Full Text] [Related]
5. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
7. Adult renal cell carcinoma with rhabdoid differentiation: incidence and clinicopathologic features in Chinese patients.
Yang X; Xi C; Jin J; Zhou L; Su J; Liu L; Liu Y
Ann Diagn Pathol; 2015 Apr; 19(2):57-63. PubMed ID: 25708024
[TBL] [Abstract][Full Text] [Related]
8. Fas (APO-1/CD95) ligand and Fas expression in renal cell carcinomas: correlation with the prognostic factors.
Kim YS; Kim KH; Choi JA; Lee JH; Kim HK; Won NH; Kim I
Arch Pathol Lab Med; 2000 May; 124(5):687-93. PubMed ID: 10782148
[TBL] [Abstract][Full Text] [Related]
9. Sarcomatoid renal cell carcinoma. A study of its proliferative activity.
Oda H; Machinami R
Cancer; 1993 Apr; 71(7):2292-8. PubMed ID: 8095849
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of Fas and Fas ligand in sarcomatoid renal cell carcinoma.
Leroy X; Wacrenier A; De la Taille A; Gosset P; Saint F; Biserte J; Gosselin B
APMIS; 2001 Jun; 109(6):469-73. PubMed ID: 11506480
[TBL] [Abstract][Full Text] [Related]
11. Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Toi M; Hiroi M; Enzan H
Histol Histopathol; 2003 Apr; 18(2):551-5. PubMed ID: 12647806
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic and Immunohistochemical Characterization of Sarcomatoid Chromophobe Renal Cell Carcinoma: An Analysis of 22 Cases.
Whaley RD; Cheng L
Am J Surg Pathol; 2022 Sep; 46(9):1171-1179. PubMed ID: 35687360
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
